<?xml version="1.0" encoding="utf-8"?>
<export-example>
  <doc>
    <id>5541</id>
    <completedYear/>
    <publishedYear>2016</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst>61</pageFirst>
    <pageLast>79</pageLast>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume/>
    <articleNumber/>
    <type>bookpart</type>
    <publisherName>Wiley</publisherName>
    <publisherPlace>Weinheim</publisherPlace>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>--</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">A Review of the Pharmaceutical R&amp;D Efficiency: Costs, Timelines, and Probabilities</title>
    <parentTitle language="eng">Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation</parentTitle>
    <identifier type="isbn">978-3-527-69343-6</identifier>
    <identifier type="isbn">978-3-527-33913-6</identifier>
    <enrichment key="opus_doi_flag">true</enrichment>
    <enrichment key="opus_import_data">{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T12:06:24Z","timestamp":1714997184669},"edition-number":"1","reference-count":47,"publisher":"Wiley","isbn-type":[{"value":"9783527339136","type":"print"},{"value":"9783527693405","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,16]]},"DOI":"10.1002\/9783527693405.ch4","type":"other","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T21:31:41Z","timestamp":1452979901000},"page":"60-79","source":"Crossref","is-referenced-by-count":7,"title":["A Review of the Pharmaceutical R&amp;amp;D Efficiency: Costs, Timelines, and Probabilities"],"prefix":"10.1002","author":[{"given":"Alexander","family":"Schuhmacher","sequence":"first","affiliation":[]},{"given":"Oliver","family":"Gassmann","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Hinder","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.25.2.420"},{"key":"e_1_2_1_3_2","first-page":"130","volume":"19","author":"Agarwal C.P.","year":"2007","journal-title":"Health Econ."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4089"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4090"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3744"},{"key":"e_1_2_1_7_2","first-page":"618","volume":"3","author":"Carpenter D.","year":"2003","journal-title":"Health Aff."},{"key":"e_1_2_1_8_2","unstructured":"CMR International(2013)CMR International Pharmaceutical R&amp;D Factbook http:\/\/cmr.thomsonreuters.com\/services\/factbook\/(accessed 25 August 2015)."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1610"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2012.09.006"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4309"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/mde.1343"},{"key":"e_1_2_1_13_2","unstructured":"Deloitte &amp; Thomson Reuters(2013)Measuring the Return from Pharmaceutical Innovation 2013."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1382"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-6296(91)90001-4"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.115446"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(02)00126-1"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(02)00126-1"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-6296(91)90001-4"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/2168479014521419"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mde.1360"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.295"},{"key":"e_1_2_1_23_2","unstructured":"European Commission \u2013 Joint Research Centre(2013)The 2013 EU Industrial R&amp;D Investment Scoreboard."},{"key":"e_1_2_1_24_2","unstructured":"EvaluatePharma(2013)Biotech and Pharma 2012 Year in Review."},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.36.7.804"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-6296(94)90010-8"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200018001-00005"},{"key":"e_1_2_1_28_2","unstructured":"International Federation of Pharmaceutical Manufacturers &amp; AssociationsThe Pharmaceutical Industry and Global Health \u2013 Facts and Figures2014."},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-6296(86)90003-2"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.286"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1470"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3514"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2961"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijindorg.2008.04.003"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3405"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3078"},{"key":"e_1_2_1_37_2","unstructured":"PhRMA(2013)Profile Biopharmaceutical Research Industry http:\/\/www.phrma.org\/sites\/default\/files\/pdf\/PhRMA%20Profile%202013.pdf(accessed 01 November 2014)."},{"key":"e_1_2_1_38_2","unstructured":"PWC(2012)From Vision to Decision Pharma 2020"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1178"},{"key":"e_1_2_1_40_2","unstructured":"Remnant J.et al. (2013)Measuring the Return from Pharmaceutical Innovation 2013 http:\/\/thomsonreuters.com\/business\u2010unit\/science\/subsector\/pdf\/uk\u2010manufacturing\u2010measuring\u2010the\u2010return\u2010from\u2010pharmaceutical\u2010innovation\u20102013.pdf(accessed 25 August 2015)."},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(04)03316-1"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3681"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4320"},{"key":"e_1_2_1_44_2","unstructured":"Schulze U. B\u00e4deker M. Chen Y.T. andGreber D.(2015) BCG Perspectives R&amp;D Production 2014: A Breakthrough year for Biopharma."},{"key":"e_1_2_1_45_2","first-page":"6763","volume":"10","author":"Simon R.","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3480"},{"key":"e_1_2_1_47_2","unstructured":"Thomson Reuters(2013)CMR International Pharmaceutical R&amp;D Factbook http:\/\/cmr.thomsonreuters.com\/pdf\/fb\u2010exec\u20102013.pdf(accessed 07 November 2014)."},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3555"}],"container-title":["Value Creation in the Pharmaceutical Industry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2F9783527693405.ch4","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9783527693405.ch4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T13:34:33Z","timestamp":1693143273000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9783527693405.ch4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"ISBN":["9783527339136","9783527693405"],"references-count":47,"alternative-id":["10.1002\/9783527693405.ch4","10.1002\/9783527693405"],"URL":"https:\/\/doi.org\/10.1002\/9783527693405.ch4","archive":["Portico"],"relation":{},"subject":[],"published":{"date-parts":[[2016,1,15]]}}}</enrichment>
    <enrichment key="local_crossrefDocumentType">other</enrichment>
    <enrichment key="local_import_origin">crossref</enrichment>
    <enrichment key="local_doiImportPopulated">PersonAuthorFirstName_1,PersonAuthorLastName_1,PersonAuthorFirstName_2,PersonAuthorLastName_2,PersonAuthorFirstName_3,PersonAuthorLastName_3,PublisherName,TitleMain_1,Language,TitleParent_1,PageNumber,PageFirst,PageLast,Edition,CompletedYear,IdentifierIsbn</enrichment>
    <enrichment key="opus.source">doi-import</enrichment>
    <enrichment key="THI_openaccess">nein</enrichment>
    <enrichment key="THI_relatedIdentifier">https://doi.org/10.1002/9783527693405.ch4</enrichment>
    <author>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </author>
    <editor>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </editor>
    <author>
      <first_name>Oliver</first_name>
      <last_name>Gassmann</last_name>
    </author>
    <editor>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </editor>
    <author>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </author>
    <editor>
      <first_name>Oliver</first_name>
      <last_name>Gassmann</last_name>
    </editor>
    <collection role="persons" number="44756">Schuhmacher, Alexander</collection>
  </doc>
  <doc>
    <id>5542</id>
    <completedYear/>
    <publishedYear>2016</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst>203</pageFirst>
    <pageLast>223</pageLast>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume/>
    <articleNumber/>
    <type>bookpart</type>
    <publisherName>Wiley</publisherName>
    <publisherPlace>Weinheim</publisherPlace>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>--</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">The Evolution of Clinical Development: From Technical Success to Clinical Value Creation</title>
    <parentTitle language="eng">Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation</parentTitle>
    <identifier type="isbn">978-3-527-69343-6</identifier>
    <identifier type="isbn">978-3-527-33913-6</identifier>
    <enrichment key="opus_doi_flag">true</enrichment>
    <enrichment key="opus_import_data">{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:40:10Z","timestamp":1718314810830},"edition-number":"1","reference-count":121,"publisher":"Wiley","isbn-type":[{"value":"9783527339136","type":"print"},{"value":"9783527693405","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,16]]},"DOI":"10.1002\/9783527693405.ch10","type":"other","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T21:31:41Z","timestamp":1452979901000},"page":"202-223","source":"Crossref","is-referenced-by-count":0,"title":["The Evolution of Clinical Development: From Technical Success to Clinical Value Creation"],"prefix":"10.1002","author":[{"given":"Markus","family":"Hinder","sequence":"first","affiliation":[]},{"given":"Alexander","family":"Schuhmacher","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.1995.00430040023003","article-title":"The role of nitrates in coronary heart disease","volume":"155","author":"Abrams J.","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.02.007"},{"key":"e_1_2_1_4_2","unstructured":"Allen J. Marks L. andArroyo S.(2014) Imagine running clinical trials together: what would this look like?Disruptive Innovations The Fairmont Copley Plaza September 11\u201312 2014."},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.032"},{"issue":"6","key":"e_1_2_1_6_2","first-page":"2013","article-title":"Restoring confidence in the pharmaceutical industry","volume":"309","author":"Bauchner H.","year":"2014","journal-title":"JAMA"},{"key":"e_1_2_1_7_2","unstructured":"Belluck P.(2010) The vanishing mind.Alzheimer's Stalks a Colombian Family. New York Times p.A1."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.11.012"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.15"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.02.002"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3802"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/11599010-000000000-00000"},{"key":"e_1_2_1_13_2","unstructured":"Cattell J. Chilukuri S. andLevy M.(2013)How Big Data Can Revolutionize Pharmaceutical R &amp; D April 2013."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/CVM-2-1-002"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(02)00389-3"},{"key":"e_1_2_1_16_2","unstructured":"Covington M.(2013)Diversity in Clinical Trials \u2013 And Why It Matters Speaking of Sanofi http:\/\/blog.sanofi.us\/2013\/05\/23\/diversity\u2010in\u2010clinical\u2010trials\/(accessed 12 August 2015)."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-005-9002-0"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2008.01.007"},{"issue":"2","key":"e_1_2_1_19_2","first-page":"S15","article-title":"Role of nitrates for the therapy of coronary artery disease patients in the years beyond 2000","volume":"34","author":"Darius H.","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.295"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.9.905"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1086\/592068"},{"key":"e_1_2_1_23_2","unstructured":"Dole K. Orloff J. Gleeson G. Nelson A. andVan Dam J.(2014) Innovation in alternative clinical settings: the walgreens\u2010novartis collaboration.Disruptive Innovations The Fairmont Copley Plaza September 11\u201312 2014."},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282034"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3401"},{"key":"e_1_2_1_26_2","unstructured":"EFPIA(2013)The Pharmaceutical Industry in Figures. Key Data 2013 pp.1\u201328."},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.14"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3501"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.14.1552"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2010.19.5.47064"},{"key":"e_1_2_1_31_2","unstructured":"EMA(2013)Guideline on Clinical Investigation of Medicinal Products in the Treatment of Depression May 2013 pp.1\u201319."},{"key":"e_1_2_1_32_2","unstructured":"EMA(2014)Clinical Efficacy and Safety: Anti\u2010Infectives for Systemic Use http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/general\/general_content_000401.jsp&amp;mid=WC0b01ac0580034cf2(accessed 12 August 2015)."},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs196"},{"key":"e_1_2_1_35_2","unstructured":"EUnetHTA \u2013 European network for Health Technology Assessment(2015)COMPARATORS &amp; COMPARISONS. Guideline on Criteria for the Choice of the Most Appropriate Comparator(s) Summary of Current Policies and Best Practice Recommendations pp.1\u201324.https:\/\/eunethta.fedimbo.belgium.be\/sites\/5026.fedimbo.belgium.be\/files\/news\u2010attachments\/2015\u201010\u201002_md_gl_sag_publiccons.pdf."},{"key":"e_1_2_1_36_2","unstructured":"FDA(2011)Guidance for Industry and Food and Drug Administration Staff Clinical Investigations of Devices Indicated for the Treatment of Urinary Incontinence."},{"key":"e_1_2_1_37_2","unstructured":"FDA(2013)Paving the Way for Personalized Medicine."},{"issue":"175","key":"e_1_2_1_38_2","first-page":"97","article-title":"Agency : action","volume":"73","author":"Food and Drug Administration","year":"2008","journal-title":"Fed. Regist."},{"key":"e_1_2_1_39_2","unstructured":"Food and Drug Administration(2014)Public Workshop \u2013 Complex Issues in Developing Drug and Biological Products for Rare Diseases http:\/\/www.fda.gov\/drugs\/newsevents\/ucm367820.htm(accessed 12 August 2015)."},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.07.006"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/CVM-2-5-205"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.157172"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.912550"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.919456"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1006304"},{"key":"e_1_2_1_46_2","unstructured":"Haslam J.andKim J.(2014) Social media revolution in clinical trials: when?Disruptive Innovations The Fairmont Copley Plaza September 11\u201312 2014."},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00746.x"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.11.019"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.09.002"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.200410084"},{"key":"e_1_2_1_51_2","unstructured":"ICH E14(2005)Guidance for Industry Interval Prolongation and Guidance for Industry.U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) October 2005."},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1159\/000353454"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.293"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70169-8"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e31818881ca"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100479"},{"key":"e_1_2_1_57_2","unstructured":"Korsan B. Dykstra K. andPullman W.(2005)A Clinical Utility Index (CUI) Openly Evaluates a Product's Attributes \u2014 and Chance. Pharmaceutical Executive March 2005."},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.676"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.800292"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/504198a"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2012.42.9.583"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.2217\/pme.11.7"},{"key":"e_1_2_1_63_2","unstructured":"Loftus P.(2011)Merck Teams Up with Parexel on Biosimilars. Wall Street Journal."},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-011-0396-7"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2013.04.001"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2008.036"},{"key":"e_1_2_1_67_2","first-page":"789","article-title":"A study of the effects of hypoglycemic agents on vascular complications in patients with adult\u2010onset diabetes. II. Mortality results","volume":"19","author":"Meinert C.L.","year":"1970","journal-title":"Diabetes"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1520-765X(01)90011-2"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.03.004"},{"issue":"141","key":"e_1_2_1_70_2","first-page":"98","article-title":"Orphan drugs assessment in the centralised procedure","volume":"47","author":"Nistic\u00f2 G.","year":"2011","journal-title":"Ann. Ist. Super. Sanita"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"e_1_2_1_72_2","unstructured":"Novartis(2013)The Novartis Malaria Initiative in Zambia Engagement in Zambia across Novartis divisions August."},{"key":"e_1_2_1_73_2","unstructured":"Novartis Institutes of Biomedical Research(2013)Advancing Global Health."},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/506150a"},{"key":"e_1_2_1_75_2","first-page":"8","article-title":"Innovative approaches to clinical development and trial design","volume":"47","author":"Orloff J.J.","year":"2011","journal-title":"Ann. Ist. Super. Sanita"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3025"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740330903499265"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.03.009"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005281818"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.11.016"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.03.004"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2006.00701.x"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.085"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6052"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100130"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.71"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1178"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.06.012"},{"key":"e_1_2_1_89_2","unstructured":"Roche(2012)Roche provides update on Phase III study of dalcetrapib. Media Release May 07."},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61454-9"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7023.71"},{"key":"e_1_2_1_92_2","unstructured":"Sanofi\u2010Aventis(2009)MULTAQ\u00ae (DRONEDARONE) Briefing Document Advisory Committee Meeting of the Cardiovascular and Renal Drugs Division of the US Food and Drug Administration FDA March 18 2009 http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/09\/briefing\/2009\u20104417b1\u201002\u2010Sanofi_Aventis.pdf(accessed 14 November 2015)."},{"key":"e_1_2_1_93_2","volume-title":"Pharmaceutical and Medical Products Practice","author":"Sartori V.","year":"2011"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-12-106"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3445"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12191"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.5.836"},{"issue":"2","key":"e_1_2_1_98_2","first-page":"126","article-title":"Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials","volume":"19","author":"Smith G.C.S.","year":"2003","journal-title":"Br. Med. J."},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.865444"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.9.831"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4849"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2012.1210"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.10.001"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802448056"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6815-11-1"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001097"},{"issue":"3","key":"e_1_2_1_108_2","first-page":"205","article-title":"How to optimize patient recruitment","volume":"53","author":"Thoma A.","year":"2010","journal-title":"Can. J. Surg."},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12230"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.133"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2251"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-072X-7-26"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005151.pub2"},{"key":"e_1_2_1_115_2","unstructured":"WHO(1999)Genetics and Diabetes pp.1\u201315 http:\/\/www.who.int\/genomics\/about\/Diabetis\u2010fin.pdf(accessed 12 August 2015)."},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.43"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100063"},{"key":"e_1_2_1_118_2","unstructured":"Wright T.M.(2012)Focusing on Patients Following the Science. Novartis R&amp;D Investor Day Boston November 8 2012 https:\/\/www.yumpu.com\/en\/document\/view\/13994041\/focusing\u2010on\u2010patients\u2010following\u2010the\u2010science\u201025\u2010mb\u2010novartis."},{"key":"e_1_2_1_119_2","unstructured":"Wright R.(2014a)Merck Serono's CEO Bel\u00e9n Garijo \u2013 Enabling Risk and Refusing to Play It Safe. Life Science Leader Magazine."},{"key":"e_1_2_1_120_2","unstructured":"Wright R.(2014b)Reader Disputes Merck\u2010Serono\/Quintiles Collaboration As Being Game Changing. Life Science Leader Magazine."},{"key":"e_1_2_1_121_2","unstructured":"Zerhouni E.A.(2013)JP Morgan Healthcare Conference San Francisco CA January 8 2013 http:\/\/www.sanofi.com\/Images\/31656_2013\u201001\u201008_JPMorgan_Zerhouni.pdf(accessed 14 November 2015)."},{"key":"e_1_2_1_122_2","first-page":"17","article-title":"Pharmacokinetic drug\u2010drug interactions between 1,4\u2010dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management","volume":"10","author":"Zhou Y.\u2010T.","year":"2014","journal-title":"Ther. Clin. Risk Manage."}],"container-title":["Value Creation in the Pharmaceutical Industry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2F9783527693405.ch10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9783527693405.ch10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:00:39Z","timestamp":1718312439000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9783527693405.ch10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"ISBN":["9783527339136","9783527693405"],"references-count":121,"alternative-id":["10.1002\/9783527693405.ch10","10.1002\/9783527693405"],"URL":"https:\/\/doi.org\/10.1002\/9783527693405.ch10","archive":["Portico"],"relation":{},"subject":[],"published":{"date-parts":[[2016,1,15]]}}}</enrichment>
    <enrichment key="local_crossrefDocumentType">other</enrichment>
    <enrichment key="local_import_origin">crossref</enrichment>
    <enrichment key="local_doiImportPopulated">PersonAuthorFirstName_1,PersonAuthorLastName_1,PersonAuthorFirstName_2,PersonAuthorLastName_2,PublisherName,TitleMain_1,Language,TitleParent_1,PageNumber,PageFirst,PageLast,Edition,CompletedYear,IdentifierIsbn</enrichment>
    <enrichment key="opus.source">doi-import</enrichment>
    <enrichment key="THI_relatedIdentifier">https://doi.org/10.1002/9783527693405.ch10</enrichment>
    <enrichment key="THI_openaccess">nein</enrichment>
    <author>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </author>
    <editor>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </editor>
    <author>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </author>
    <editor>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </editor>
    <editor>
      <first_name>Oliver</first_name>
      <last_name>Gassmann</last_name>
    </editor>
    <collection role="persons" number="44756">Schuhmacher, Alexander</collection>
  </doc>
  <doc>
    <id>5543</id>
    <completedYear/>
    <publishedYear>2016</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst>335</pageFirst>
    <pageLast>361</pageLast>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume/>
    <articleNumber/>
    <type>bookpart</type>
    <publisherName>Wiley</publisherName>
    <publisherPlace>Weinheim</publisherPlace>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>--</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">The Pharmaceutical Industry is Opening Its R&amp;D Boundaries</title>
    <parentTitle language="eng">Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation</parentTitle>
    <identifier type="isbn">978-3-527-69343-6</identifier>
    <identifier type="isbn">978-3-527-33913-6</identifier>
    <enrichment key="opus_doi_flag">true</enrichment>
    <enrichment key="opus_import_data">{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:40:36Z","timestamp":1718314836020},"edition-number":"1","reference-count":34,"publisher":"Wiley","isbn-type":[{"value":"9783527339136","type":"print"},{"value":"9783527693405","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,16]]},"DOI":"10.1002\/9783527693405.ch15","type":"other","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T21:31:41Z","timestamp":1452979901000},"page":"334-361","source":"Crossref","is-referenced-by-count":1,"title":["The Pharmaceutical Industry is Opening Its R&amp;amp;D Boundaries"],"prefix":"10.1002","author":[{"given":"Alexander","family":"Schuhmacher","sequence":"first","affiliation":[]},{"given":"Ulrich A. K.","family":"Betz","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"Adams M.(2010)Datamonitor \u2013 Pharmaceutical Licensing Overview http:\/\/about.datamonitor.com\/media\/archives\/4097(accessed 30 November 2014)."},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4089"},{"key":"e_1_2_1_4_2","unstructured":"Behnke N.andHueltenschmidt N.(2010)Bain &amp; Co. Insight. Changing Pharma's Innovation DNA www.bain.com\/publications\/articles\/changing\u2010pharmas\u2010innovation\u2010dna.aspx(accessed 30 November 2014)."},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.04.012"},{"key":"e_1_2_1_6_2","volume-title":"Innovation and Marketing in the Pharmaceutical Industry, Emerging Practices, Research, and Policies","author":"Betz U.A.K.","year":"2014"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.2174\/2213809901666140401202431"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-8349-8255-1_5"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3112"},{"key":"e_1_2_1_10_2","first-page":"xxviii","volume-title":"Open Innovation. The New Imperative for Creating and Profiting from Technology","author":"Chesbrough H.W.","year":"2003"},{"issue":"12","key":"e_1_2_1_11_2","first-page":"68","volume":"87","author":"Chesbrough H.W.","year":"2009","journal-title":"Harv. Bus. Rev."},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780199290727.001.0001","volume-title":"Open Innovation \u2013 Researching a New Paradigm","author":"Chesbroug H.","year":"2006"},{"key":"e_1_2_1_13_2","unstructured":"Chew J.(2010)Big Pharma: Why In\u2010Licensing is Not the Cure http:\/\/seekingalpha.com\/article\/222782\u2010big\u2010pharma\u2010why\u2010in\u2010licensing\u2010is\u2010not\u2010the\u2010cure(accessed 11 August 2015)."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2010.11.012"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/470154a"},{"key":"e_1_2_1_16_2","volume-title":"Evolution or Revolution. McKinsey Perspectives on Drug and Device R&amp;D in 2012","author":"Dhankar A.","year":"2011"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3462"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09107"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.3139\/9783446426498"},{"key":"e_1_2_1_20_2","unstructured":"Gassmann O.andEnkel E.(2004) Towards a theory of open innovation: three core process archetypes.Proceedings of the R&amp;D Management Conference (RADMA) Sesimbra Portugal July 8\u20139 2004."},{"key":"e_1_2_1_21_2","first-page":"15","author":"Godin G.","year":"2005","journal-title":"Drug Discovery World"},{"key":"e_1_2_1_22_2","unstructured":"Hu M.(2007)Kellogg School of Management. The Innovation Gap in Pharmaceutical Drug Discovery &amp; New Models for R&amp;D Success www.kellog.northwestern.edu(accessed 30 November 2014)."},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.10.230"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2010.11.013"},{"issue":"1","key":"e_1_2_1_25_2","first-page":"45","volume":"53","author":"Lichtenthaler U.","year":"2011","journal-title":"MIT Sloan Manage. Rev."},{"issue":"5","key":"e_1_2_1_26_2","first-page":"1","volume":"25","author":"Longman R.","year":"2007","journal-title":"In Vivo"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/08956308.2007.11657438","volume":"5","author":"Mehta S.","year":"2007","journal-title":"Res. Technol. Manage."},{"key":"e_1_2_1_28_2","volume-title":"Strategisches Management","author":"M\u00fcller Stewens G.","year":"2011"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1230"},{"issue":"10","key":"e_1_2_1_30_2","first-page":"114","volume":"84","author":"Pisano G.","year":"2006","journal-title":"Harv. Bus. Rev."},{"issue":"4","key":"e_1_2_1_31_2","first-page":"13","volume":"41","author":"Quinn J.B.","year":"2000","journal-title":"MIT Sloan Manage. Rev."},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0111-3"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(04)03316-1"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.07.013"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.59.090506.155819"}],"container-title":["Value Creation in the Pharmaceutical Industry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2F9783527693405.ch15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9783527693405.ch15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:00:09Z","timestamp":1718312409000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9783527693405.ch15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"ISBN":["9783527339136","9783527693405"],"references-count":34,"alternative-id":["10.1002\/9783527693405.ch15","10.1002\/9783527693405"],"URL":"https:\/\/doi.org\/10.1002\/9783527693405.ch15","archive":["Portico"],"relation":{},"subject":[],"published":{"date-parts":[[2016,1,15]]}}}</enrichment>
    <enrichment key="local_crossrefDocumentType">other</enrichment>
    <enrichment key="local_import_origin">crossref</enrichment>
    <enrichment key="local_doiImportPopulated">PersonAuthorFirstName_1,PersonAuthorLastName_1,PersonAuthorFirstName_2,PersonAuthorLastName_2,PublisherName,TitleMain_1,Language,TitleParent_1,PageNumber,PageFirst,PageLast,Edition,CompletedYear,IdentifierIsbn</enrichment>
    <enrichment key="opus.source">doi-import</enrichment>
    <enrichment key="THI_openaccess">nein</enrichment>
    <enrichment key="THI_relatedIdentifier">https://doi.org/10.1002/9783527693405.ch15</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <author>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </author>
    <editor>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </editor>
    <author>
      <first_name>Ulrich A. K.</first_name>
      <last_name>Betz</last_name>
    </author>
    <editor>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </editor>
    <editor>
      <first_name>Oliver</first_name>
      <last_name>Gassmann</last_name>
    </editor>
    <collection role="persons" number="44756">Schuhmacher, Alexander</collection>
  </doc>
  <doc>
    <id>4597</id>
    <completedYear/>
    <publishedYear>2022</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst>257</pageFirst>
    <pageLast>279</pageLast>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume/>
    <articleNumber/>
    <type>bookpart</type>
    <publisherName>Wiley-VCH</publisherName>
    <publisherPlace>Weinheim</publisherPlace>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>1</belongsToBibliography>
    <completedDate>--</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">Project, Risk, and Portfolio Management – Managing R &amp; D Projects Today*</title>
    <parentTitle language="eng">Principles of Biomedical Sciences and Industry: Translating Ideas into Treatments</parentTitle>
    <identifier type="isbn">978-3-527-34571-7</identifier>
    <identifier type="isbn">978-3-527-82401-4</identifier>
    <enrichment key="opus_doi_flag">true</enrichment>
    <enrichment key="opus_import_data">{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T04:39:28Z","timestamp":1692679168238},"edition-number":"1","reference-count":19,"publisher":"Wiley","isbn-type":[{"value":"9783527345717","type":"print"},{"value":"9783527824014","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,3]]},"DOI":"10.1002\/9783527824014.ch14","type":"other","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T21:37:43Z","timestamp":1658525863000},"page":"257-279","source":"Crossref","is-referenced-by-count":0,"title":["Project, Risk, and Portfolio Management \u2013 Managing\n            &lt;scp&gt;R&lt;\/scp&gt;\n            &amp;amp;\n            &lt;scp&gt;D&lt;\/scp&gt;\n            Projects Today*"],"prefix":"10.1002","author":[{"given":"Alexander","family":"Schuhmacher","sequence":"first","affiliation":[]},{"given":"Markus","family":"Hinder","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.04.012"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1057\/palgrave.jcb.3040113"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1057\/jcb.2008.6"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-66833-8"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-66833-8_1"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.36.7.804"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-6296(94)90010-8"},{"key":"e_1_2_1_9_1","unstructured":"International Project Management Association(2017).IPMA competence baseline (ICB) version 4.0.https:\/\/www.gpm\u2010ipma.de\/fileadmin\/user_upload\/GPM\/Know\u2010How\/programm\u2010icb4\/IPMA_ICB4_PM_deutsch_170213.pdf(accessed 11 November 2020)."},{"key":"e_1_2_1_10_1","unstructured":"ISO 10006: 2017(2017).Quality management \u2013 guidelines for quality management in projects.https:\/\/www.iso.org\/standard\/70376.html(accessed 23 March 2021)."},{"key":"e_1_2_1_11_1","unstructured":"ISO 21500: 2013(2013).Guidance on project management.https:\/\/www.iso.org\/standard\/50003.html."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-6296(86)90003-2"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/08956308.2005.11657313"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/08832323.1992.10117582"},{"issue":"1","key":"e_1_2_1_15_1","first-page":"12","article-title":"Can project management be defined?","volume":"2","author":"Olsen R.P.","year":"1971","journal-title":"Project Manag. Quart."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3078"},{"key":"e_1_2_1_17_1","volume-title":"A Guide to Project Management Body of Knowledge (PMBOK\n                        \u00ae\n                         Guide)","author":"Project Management Institute","year":"2017"},{"key":"e_1_2_1_18_1","volume-title":"Diffusion of Innovations","author":"Rogers E.M.","year":"1983"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0838-4"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.06.015"}],"container-title":["Principles of Biomedical Sciences and Industry"],"original-title":[],"link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9783527824014.ch14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9783527824014.ch14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T03:52:42Z","timestamp":1692589962000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9783527824014.ch14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"ISBN":["9783527345717","9783527824014"],"references-count":19,"alternative-id":["10.1002\/9783527824014.ch14","10.1002\/9783527824014"],"URL":"http:\/\/dx.doi.org\/10.1002\/9783527824014.ch14","archive":["Portico"],"relation":{},"published":{"date-parts":[[2022,7,22]]}}}</enrichment>
    <enrichment key="local_crossrefDocumentType">other</enrichment>
    <enrichment key="local_crossrefLicence">http://doi.wiley.com/10.1002/tdm_license_1.1</enrichment>
    <enrichment key="local_import_origin">crossref</enrichment>
    <enrichment key="local_doiImportPopulated">PersonAuthorFirstName_1,PersonAuthorLastName_1,PersonAuthorFirstName_2,PersonAuthorLastName_2,PublisherName,TitleMain_1,TitleParent_1,PageNumber,PageFirst,PageLast,Edition,CompletedYear,IdentifierIsbn,Enrichmentlocal_crossrefLicence</enrichment>
    <enrichment key="opus.source">doi-import</enrichment>
    <enrichment key="THI_relatedIdentifier">https://doi.org/10.1002/9783527824014.ch14</enrichment>
    <enrichment key="THI_openaccess">nein</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <author>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </author>
    <editor>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </editor>
    <author>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </author>
    <editor>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </editor>
    <editor>
      <first_name>Jörg</first_name>
      <last_name>Goldhahn</last_name>
    </editor>
    <editor>
      <first_name>Dominik</first_name>
      <last_name>Hartl</last_name>
    </editor>
    <collection role="institutes" number="15986">THI Business School</collection>
    <collection role="persons" number="44756">Schuhmacher, Alexander</collection>
  </doc>
  <doc>
    <id>4575</id>
    <completedYear/>
    <publishedYear>2022</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst>1</pageFirst>
    <pageLast>6</pageLast>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume/>
    <articleNumber/>
    <type>bookpart</type>
    <publisherName>Wiley-VCH</publisherName>
    <publisherPlace>Weinheim</publisherPlace>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>1</belongsToBibliography>
    <completedDate>--</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">Biopharmaceutical Innovation at a Glance</title>
    <parentTitle language="eng">Principles of Biomedical Sciences and Industry: Translating Ideas into Treatments</parentTitle>
    <identifier type="isbn">978-3-527-34571-7</identifier>
    <identifier type="isbn">978-3-527-82401-4</identifier>
    <enrichment key="opus_doi_flag">true</enrichment>
    <enrichment key="opus_import_data">{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T05:03:37Z","timestamp":1692680617568},"edition-number":"1","reference-count":10,"publisher":"Wiley","isbn-type":[{"value":"9783527345717","type":"print"},{"value":"9783527824014","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,3]]},"DOI":"10.1002\/9783527824014.ch1","type":"other","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T21:37:43Z","timestamp":1658525863000},"page":"1-6","source":"Crossref","is-referenced-by-count":0,"title":["Biopharmaceutical Innovation at a Glance"],"prefix":"10.1002","author":[{"given":"Markus","family":"Hinder","sequence":"first","affiliation":[]},{"given":"Dominik","family":"Hartl","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Schuhmacher","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"e_1_2_1_2_1","volume-title":"Papyrus Ebers","author":"No author"},{"key":"e_1_2_1_3_1","volume-title":"Papyrus Lahun","author":"No author"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.11.012"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5460.1960"},{"key":"e_1_2_1_6_1","unstructured":"ICH(n.d.).International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).https:\/\/www.ich.org\/(accessed 3 October 2020)."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.613"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0838-4"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.2.404"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2251"},{"key":"e_1_2_1_11_1","unstructured":"Waters R.andUrquhart L.(2019).Evaluate Pharma. World Preview Outlook to 2024.https:\/\/www.evaluate.com\/thought\u2010leadership\/pharma\/evaluatepharma\u2010world\u2010preview\u20102019\u2010outlook\u20102024(accessed 27 September 2020)."}],"container-title":["Principles of Biomedical Sciences and Industry"],"original-title":[],"link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9783527824014.ch1","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9783527824014.ch1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T03:54:12Z","timestamp":1692590052000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9783527824014.ch1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"ISBN":["9783527345717","9783527824014"],"references-count":10,"alternative-id":["10.1002\/9783527824014.ch1","10.1002\/9783527824014"],"URL":"http:\/\/dx.doi.org\/10.1002\/9783527824014.ch1","archive":["Portico"],"relation":{},"published":{"date-parts":[[2022,7,22]]}}}</enrichment>
    <enrichment key="local_crossrefDocumentType">other</enrichment>
    <enrichment key="local_crossrefLicence">http://doi.wiley.com/10.1002/tdm_license_1.1</enrichment>
    <enrichment key="local_import_origin">crossref</enrichment>
    <enrichment key="local_doiImportPopulated">PersonAuthorFirstName_1,PersonAuthorLastName_1,PersonAuthorFirstName_2,PersonAuthorLastName_2,PersonAuthorFirstName_3,PersonAuthorLastName_3,PublisherName,TitleMain_1,TitleParent_1,PageNumber,PageFirst,PageLast,Edition,CompletedYear,IdentifierIsbn,Enrichmentlocal_crossrefLicence</enrichment>
    <enrichment key="opus.source">doi-import</enrichment>
    <enrichment key="THI_relatedIdentifier">https://doi.org/10.1002/9783527824014.ch1</enrichment>
    <enrichment key="THI_openaccess">nein</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <author>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </author>
    <editor>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </editor>
    <author>
      <first_name>Dominik</first_name>
      <last_name>Hartl</last_name>
    </author>
    <editor>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </editor>
    <author>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </author>
    <editor>
      <first_name>Jörg</first_name>
      <last_name>Goldhahn</last_name>
    </editor>
    <editor>
      <first_name>Dominik</first_name>
      <last_name>Hartl</last_name>
    </editor>
    <collection role="institutes" number="15986">THI Business School</collection>
    <collection role="persons" number="44756">Schuhmacher, Alexander</collection>
  </doc>
  <doc>
    <id>5544</id>
    <completedYear/>
    <publishedYear>2016</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst>401</pageFirst>
    <pageLast>415</pageLast>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume/>
    <articleNumber/>
    <type>bookpart</type>
    <publisherName>Wiley</publisherName>
    <publisherPlace>Weinheim</publisherPlace>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>--</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">New Innovation Models in Pharmaceutical R&amp;D</title>
    <parentTitle language="eng">Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation</parentTitle>
    <identifier type="isbn">978-3-527-69343-6</identifier>
    <identifier type="isbn">978-3-527-33913-6</identifier>
    <enrichment key="opus_doi_flag">true</enrichment>
    <enrichment key="opus_import_data">{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:40:37Z","timestamp":1718314837193},"edition-number":"1","reference-count":35,"publisher":"Wiley","isbn-type":[{"value":"9783527339136","type":"print"},{"value":"9783527693405","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,16]]},"DOI":"10.1002\/9783527693405.ch18","type":"other","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T21:31:41Z","timestamp":1452979901000},"page":"400-415","source":"Crossref","is-referenced-by-count":1,"title":["New Innovation Models in Pharmaceutical R&amp;amp;D"],"prefix":"10.1002","author":[{"given":"Alexander","family":"Schuhmacher","sequence":"first","affiliation":[]},{"given":"Oliver","family":"Gassmann","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Hinder","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026613666131127125858"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3744"},{"key":"e_1_2_1_4_2","unstructured":"Citeline(2015)Pharma R&amp;D Annual Review http:\/\/www.citeline.com\/wp\u2010content\/uploads\/2015\/02\/CITIF_RD_AnnualReview_031715.pdf(lastaccess: 05 November 2015)."},{"key":"e_1_2_1_5_2","unstructured":"CMR(2013)2013 CMR International Pharmaceutical R&amp;D Factbook http:\/\/cmr.thomsonreuters.com\/pdf\/fb\u2010exec\u20102013.pdf(accessed 07 November 2014)."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1610"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/470154a"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2948"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.115446"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220003-00001"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.295"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3230"},{"key":"e_1_2_1_13_2","unstructured":"Evaluate Pharma(2013)Biotech and Pharma 2012. Year in Review."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2374"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3462"},{"key":"e_1_2_1_16_2","first-page":"68","volume":"86","author":"Garnier J.P.","year":"2008","journal-title":"Harv. Bus. Rev."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3099"},{"key":"e_1_2_1_18_2","unstructured":"IMS Institute(2013)The Global Use of Medicine: Outlook Through 2017 http:\/\/www.imshealth.com\/deployedfiles\/imshealth\/Global\/Content\/Corporate\/IMS%20Health%20Institute\/Reports\/Global_Use_of_Meds_Outlook_2017\/IIHI_Global_Use_of_Meds_Report_2013.pdf(accessed 01 November 2014)."},{"key":"e_1_2_1_19_2","unstructured":"International Federation of Pharmaceutical Manufacturers &amp; Associations(2013)The Pharmaceutical Industry and Global Health \u2013 Facts and Figures2012 http:\/\/www.ifpma.org\/fileadmin\/content\/Publication\/2013\/IFPMA_\u2010_Facts_And_Figures_2012_LowResSinglePage.pdf(accessed 01 November 2014)."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3251"},{"key":"e_1_2_1_21_2","unstructured":"KPMG(2011)KPMG \u2013 Future Pharma Five Strategies to Accelerate the Transformation of the Pharmaceutical Industry By 2020 http:\/\/www.kpmg.com\/Global\/en\/IssuesAndInsights\/ArticlesPublications\/Documents\/future\u2010pharma.pdf(accessed 28 October 2014)."},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2010.11.013"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0509-502"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3857"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.26"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3078"},{"key":"e_1_2_1_27_2","unstructured":"PhRMA(2013)PhRMA \u2013 Pharmaceutical Industry 2013 Profile http:\/\/www.phrma.org\/sites\/default\/files\/pdf\/PhRMA%20Profile%202013.pdf(accessed 01 November 2014)."},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0111-3"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1347"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.respol.2006.01.006"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3681"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.07.013"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","unstructured":"Schulze U.(2014)Nature Reviews Drug Discovery 13 331\u2013332.","DOI":"10.1038\/nrd4320"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0710-631"},{"key":"e_1_2_1_35_2","volume-title":"EvaluatePharma \u2013 Biotech and Pharma 2012 Year in Review","author":"Urquhart","year":"2012"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0807-945"}],"container-title":["Value Creation in the Pharmaceutical Industry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2F9783527693405.ch18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9783527693405.ch18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:00:14Z","timestamp":1718312414000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9783527693405.ch18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"ISBN":["9783527339136","9783527693405"],"references-count":35,"alternative-id":["10.1002\/9783527693405.ch18","10.1002\/9783527693405"],"URL":"https:\/\/doi.org\/10.1002\/9783527693405.ch18","archive":["Portico"],"relation":{},"subject":[],"published":{"date-parts":[[2016,1,15]]}}}</enrichment>
    <enrichment key="local_crossrefDocumentType">other</enrichment>
    <enrichment key="local_import_origin">crossref</enrichment>
    <enrichment key="local_doiImportPopulated">PersonAuthorFirstName_1,PersonAuthorLastName_1,PersonAuthorFirstName_2,PersonAuthorLastName_2,PersonAuthorFirstName_3,PersonAuthorLastName_3,PublisherName,TitleMain_1,Language,TitleParent_1,PageNumber,PageFirst,PageLast,Edition,CompletedYear,IdentifierIsbn</enrichment>
    <enrichment key="opus.source">doi-import</enrichment>
    <enrichment key="THI_openaccess">nein</enrichment>
    <enrichment key="THI_relatedIdentifier">https://doi.org/10.1002/9783527693405.ch18</enrichment>
    <author>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </author>
    <editor>
      <first_name>Alexander</first_name>
      <last_name>Schuhmacher</last_name>
    </editor>
    <author>
      <first_name>Oliver</first_name>
      <last_name>Gassmann</last_name>
    </author>
    <editor>
      <first_name>Oliver</first_name>
      <last_name>Gassmann</last_name>
    </editor>
    <author>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </author>
    <editor>
      <first_name>Markus</first_name>
      <last_name>Hinder</last_name>
    </editor>
    <collection role="persons" number="44756">Schuhmacher, Alexander</collection>
  </doc>
</export-example>
